Breadcrumb
NIH Guide: Weekly Index for June 25, 2021
Weekly NIH Funding Opportunities and Notices
June 25, 2021
Policy Notices
-
Reiterating Organization Eligibility and Application Submission for NIH Research Enhancement Awards (R15)
(NOT-OD-21-135)National Institutes of Health
General Notices
-
Notice to Extend Eligibility for Submission to PAR-19-371, NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) due to COVID-related Disruptions
(NOT-AI-21-062)National Institute of Allergy and Infectious Diseases
-
Notice of Pre-Application Webinar for the "Early Detection Research Network" Program: RFA-CA-21-033, RFA-CA-21-034, and RFA-CA-21-035
(NOT-CA-21-088)National Cancer Institute
-
Notice of Pre-Application Webinar for Non-Human Primate Developmental Genotype-Tissue Expression Project (NHP dGTEx)
(NOT-HG-21-035)National Human Genome Research Institute
-
NIH Announces the Open Period of FY 2022 Helium-3 Requests for Medical Research
(NOT-HL-21-016)National Heart, Lung, and Blood Institute
-
Notice of Information: NIMH High-Priority Areas for Research on Women's Mental Health during the Perinatal Period
(NOT-MH-21-270)National Institute of Mental Health
-
Request for Information (RFI): Inviting Input to Broaden the Benefits of AI/ML Technologies to Reduce Health Disparities and Inequities and Enhance the Diversity of the AI/ML Workforce
(NOT-OD-21-147)National Institutes of Health
Notice of Changes to Funding Opportunities
-
Notice of Participation of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in PAR-20-125 Native American Research Centers for Health (NARCH) (S06 Clinical Trials Optional)
(NOT-AA-21-034)National Institute on Alcohol Abuse and Alcoholism
-
Notice of Correction to the Response Date for NOT-CA-087 "Request for Information on Datasets Collecting Temporally-Linked Diet, Physical Activity, and Sleep Data to Facilitate Integrated Research on 24-Hour Behavior Patterns"
(NOT-CA-21-089)National Cancer Institute
-
Notice of NIDCR Participation in RFA-CA-21-035 The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
(NOT-DE-21-005)National Institute of Dental and Craniofacial Research
-
Notice of NIDCR Participation in PAR-21-168, "Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)"
(NOT-DE-21-006)National Institute of Dental and Craniofacial Research
-
Notice of Change to NOT-NR-19-011: "Notice of NINR's Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)"
(NOT-NR-21-005)National Institute of Nursing Research
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
(NOT-CA-21-090)National Cancer Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
(NOT-CA-21-091)National Cancer Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for the NIH HEAL Initiative: Preventing Opioid Misuse and other Drug Use by Intervening on Social Determinants (R01 Clinical Trials Optional)
(NOT-DA-21-050)National Institute on Drug AbuseOffice of Behavioral and Social Sciences Research
-
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief (RM1 Clinical Trial Optional)
(NOT-NS-21-066)National Institute of Neurological Disorders and Stroke
Notices of Special Interest
-
Notice of Special Interest: Genetics of Alcohol Sensitivity and Tolerance
(NOT-AA-21-029)National Institute on Alcohol Abuse and Alcoholism
-
Notice of Special Interest: Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease
(NOT-AG-21-018)National Institute on AgingNational Institute on Alcohol Abuse and AlcoholismNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeJohn E. Fogarty International CenterNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Institute on Minority Health and Health DisparitiesDivision of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
-
Notice of Special Interest (NOSI): Harnessing Big Data to Halt HIV
(NOT-AI-21-054)National Institute of Allergy and Infectious DiseasesNational Institute on Drug AbuseNational Institute of Mental Health
-
Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide
(NOT-AI-21-057)National Institute of Allergy and Infectious DiseasesNational Institute on Drug AbuseNational Institute of Mental Health
-
Notice of Special Interest: Administrative Supplements for Cancer Moonshot awardees and Cancer Center Support Grants (CCSG) to Support Development of an "Immune Radiation Response Index (i-RRI)" for Immune Cells from Normal and Tumor Microenvironments
(NOT-CA-21-083)National Cancer Institute
-
Notice of Special Interest (NOSI): New Information Technology-Enabled Care Delivery Models to Improve Depression Care in Cancer
(NOT-CA-21-085)National Cancer Institute
-
Notice of Special Interest (NOSI): Advancing HIV/AIDS Research through Computational Neuroscience
(NOT-DA-21-030)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition
(NOT-HD-21-027)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute on Alcohol Abuse and AlcoholismNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Institute of Mental HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences Research
-
Notice of Special Interest (NOSI): Clarification of the Objectives and Program Elements in NHGRI Applications Submitted in Response to the "Ruth L. Kirschstein NRSA Institutional Research Training Grants (Parent T32)"
(NOT-HG-21-032)National Human Genome Research Institute
Funding Opportunities
-
Patient Safety Learning Laboratories: Advancing Patient Safety through Design, Systems Engineering, and Health Services Research (R18 Clinical Trial Optional)
(PA-21-266)Agency for Healthcare Research and QualityApplication Receipt Date(s): Standard dates apply The first standard due date for this FOA is September 25, 2021. All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed)
(PAR-21-249)National Eye InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional)
(PAR-21-250)National Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): Multiple dates, see announcement.
-
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
(PAR-21-275)National Institute on Minority Health and Health DisparitiesNational Institute on AgingNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Environmental Health SciencesNational Institute of Mental HealthOffice of Research on Women's HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed)
(RFA-AG-22-025)National Institute on AgingApplication Receipt Date(s): October 20, 2021
-
Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional)
(RFA-CA-21-026)National Cancer InstituteApplication Receipt Date(s): October 08, 2021
-
Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed)
(RFA-CA-21-027)National Cancer InstituteApplication Receipt Date(s): October 08, 2021
-
Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
(RFA-CA-21-040)National Cancer InstituteApplication Receipt Date(s): November 1, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement.
-
Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 - Clinical Trials Not Allowed)
(RFA-DA-22-003)National Institute on Drug AbuseApplication Receipt Date(s): February 02, 2022
-
Large Scale Mapping and/or Molecular Profiling of Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed)
(RFA-DA-22-011)National Institute on Drug AbuseApplication Receipt Date(s): October 15, 2021
-
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional)
(RFA-DC-22-001)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): Multiple dates, see announcement.
-
Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)
(RFA-DK-21-021)National Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): February 17, 2022 and October 7, 2022
-
CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)
(RFA-ES-21-006)National Institute of Environmental Health SciencesNational Institute of Allergy and Infectious DiseasesNational Eye InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R01 Clinical Trial Required)
(RFA-MH-21-240)National Institute of Mental HealthApplication Receipt Date(s): November 09, 2021
-
Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R34 Clinical Trial Required)
(RFA-MH-21-241)National Institute of Mental HealthOffice of Research on Women's HealthApplication Receipt Date(s): November 09, 2021
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: November 12, 2024
For technical issues E-mail OER Webmaster